Pulmonary Carcinoid Tumor Completed Phase 1 Trials for Trastuzumab (DB00072)
Also known as: Carcinoid tumour pulmonary / Carcinoid tumor of lung / Pulmonary carcinoid tumour
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028853 (Pulmonary Carcinoid Tumor) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | Treatment |